Abstract
The emergence of nanotechnology has revolutionized the field of cancer therapy and diagnosis, offering new avenues for more efficient and targeted treatments. A novel approach in the development of nano-bioactive materials has shown promise in improving the precision and effectiveness of both cancer therapies and diagnostic techniques. These materials, which can range from nanoparticles to nanostructured biomaterials, possess unique properties such as enhanced surface area, tunable sizes, and the ability to interact with biological systems at a molecular level. In cancer therapy, nano-bioactive materials can be engineered to deliver drugs directly to cancerous cells, reducing systemic toxicity and minimizing side effects associated with conventional treatments. This targeted drug delivery is facilitated by the specific interactions between nanomaterials and the tumor microenvironment, allowing for controlled release of therapeutic agents. Additionally, the use of these materials in combination with imaging agents enables early detection and monitoring of tumor progression, enhancing diagnostic accuracy. The ability to functionalize nanoparticles with ligands that bind selectively to cancer cell markers further improves the specificity of diagnosis and therapy. Recent developments in the design of multifunctional nanobioactive materials are also paving the way for combined therapeutic strategies, such as chemotherapy, gene therapy, and immunotherapy, all in one platform. Furthermore, these advanced materials offer the potential for real-time monitoring of treatment efficacy, providing valuable insights into tumor behavior and treatment response. As research continues, nano-bioactive materials are poised to become a cornerstone in the next generation of cancer management, offering safer, more personalized, and highly effective solutions for both therapy and diagnosis.